MERCY HOSPITAL LOGAN COUNTY — Hospital Ledger

Code	Description	Gross	Cash	Min payer	Max payer	# insurers
096	BACTERIAL AND TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM WITHOUT CC/MCC	$73,978	$48,086	—	—	58
643	ENDOCRINE DISORDERS WITH MCC	$72,855	$47,356	—	—	57
981	EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH MCC	$68,340	$44,421	—	—	57
377	GASTROINTESTINAL HEMORRHAGE WITH MCC	$63,332	$41,166	—	—	54
864	FEVER AND INFLAMMATORY CONDITIONS	$52,098	$33,864	—	—	57
559	AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH MCC	$48,822	$31,734	—	—	54
949	AFTERCARE WITH CC/MCC	$48,553	$31,559	—	—	57
982	EXTENSIVE O.R. PROCEDURES UNRELATED TO PRINCIPAL DIAGNOSIS WITH CC	$46,403	$30,162	—	—	57
560	AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH CC	$43,548	$28,306	—	—	57
281	ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH CC	$43,123	$28,030	—	—	57
RX-79826	ALTEPLASE 100 MG INTRAVENOUS SOLUTION	$39,602	$25,741	—	—	108
291	HEART FAILURE AND SHOCK WITH MCC	$38,818	$25,232	—	—	58
056	DEGENERATIVE NERVOUS SYSTEM DISORDERS WITH MCC	$30,660	$19,929	—	—	57
RX-224155	BENRALIZUMAB 30 MG/ML SUBCUTANEOUS SYRINGE	$29,290	$19,039	—	—	108
433	CIRRHOSIS AND ALCOHOLIC HEPATITIS WITH CC	$29,185	$18,970	—	—	58
561	AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITHOUT CC/MCC	$27,791	$18,064	—	—	57
190	CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MCC	$27,006	$17,554	—	—	58
919	COMPLICATIONS OF TREATMENT WITH MCC	$26,427	$17,178	—	—	54
603	CELLULITIS WITHOUT MCC	$23,273	$15,128	—	—	57
950	AFTERCARE WITHOUT CC/MCC	$23,080	$15,002	—	—	58
381	COMPLICATED PEPTIC ULCER WITH CC	$21,745	$14,134	—	—	57
RX-80908	DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION	$21,524	$13,990	—	—	103
388	GASTROINTESTINAL OBSTRUCTION WITH MCC	$17,792	$11,565	—	—	57
RX-129357	DARBEPOETIN ALFA 500 MCG/ML IN POLYSORBATE INJECTION SYRINGE	$17,415	$11,320	—	—	108
637	DIABETES WITH MCC	$16,867	$10,963	—	—	58
192	CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT CC/MCC	$15,815	$10,280	—	—	58
202	BRONCHITIS AND ASTHMA WITH CC/MCC	$15,225	$9,896	—	—	58
439	DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH CC	$14,755	$9,591	—	—	58
RX-245937	HUMAN PROTHROMBIN CMPX(PCC)-LANS 1,000 UNIT (800-1,280 UNIT) IV SOLUTION	$14,175	$9,214	—	—	107
392	ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MCC	$13,935	$9,058	—	—	58
057	DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MCC	$11,785	$7,660	—	—	58
638	DIABETES WITH CC	$11,340	$7,371	—	—	58
440	DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT CC/MCC	$9,897	$6,433	—	—	58
191	CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH CC	$9,856	$6,407	—	—	58
RX-232982	EPTINEZUMAB-JJMR 100 MG/ML INTRAVENOUS SOLUTION\|RX AMT DISCARD/NOT ADMIN TO PT	$9,441	$6,136	—	—	108
RX-190284	DENOSUMAB 60 MG/ML SUBCUTANEOUS SYRINGE\|RX AMT DISCARD/NOT ADMIN TO PT	$9,377	$6,095	—	—	108
RX-253466	DENOSUMAB-BMWO 60 MG/ML SUBCUTANEOUS SYRINGE\|RX AMT DISCARD/NOT ADMIN TO PT	$8,908	$5,790	—	—	104
RX-209792	DALBAVANCIN 500 MG INTRAVENOUS SOLUTION	$8,006	$5,204	—	—	108
RX-245938	HUMAN PROTHROMBIN CPLX(PCC)-LANS 500 UNIT (400-640 UNIT) IV SOLUTION	$7,088	$4,607	—	—	107
RX-129718	DARBEPOETIN ALFA 200 MCG/0.4 ML IN POLYSORBATE INJECTION SYRINGE	$6,966	$4,528	—	—	108
RX-196284	HYDROXOCOBALAMIN 5 GRAM INTRAVENOUS SOLUTION	$6,717	$4,366	—	—	103
305	HYPERTENSION WITHOUT MCC	$6,485	$4,215	—	—	58
PX-100001753	App Skn Sub Trk/Arm/Leg 1st 100sqcm Twsa >=100 Sqcm	$6,189	$4,023	—	—	104
RX-300910	ALTEPLASE 1 MG/ML IV SOLUTION	$5,940	$3,861	—	—	108
PX-700000668	Cta Abd Aorta Bi Iliofem W/WO	$5,444	$3,539	—	—	108
PX-100001757	App Skn Sub Hd/Nk/Hnd/Ft 1st 100sqcm< Twsa>=100 Sqcm	$5,311	$3,452	—	—	104
PX-500002004	Arthroplasty Hip Total Pf	$5,255	$3,416	—	—	107
CASE-99285	ED Visit Care Level 5	$5,087	$3,307	—	—	7
RX-182466	FERUMOXYTOL 510 MG/17 ML (30 MG/ML) INTRAVENOUS SOLUTION	$4,972	$3,232	—	—	108
PX-500001992	Arthroplasty Total Shoulder Pf	$4,938	$3,210	—	—	107

Showing top 50 of 1,869 priced procedures, sorted by gross charge.

Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.